UPC (Universe Pharmaceuticals) Ending Cash Position: $33.59 Mil (As of Sep. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

UPC Universe Pharmaceuticals Inc UPC
64 GF Score
Price $4.45
GF Value $5.17
Valuation Modestly Undervalued
! 7 Warning Signs
View Full Analysis

What is Universe Pharmaceuticals Ending Cash Position?

Universe Pharmaceuticals UPC -14.26% 64 Ending Cash Position is $33.59 Mil as of Sep. 2025. GuruFocus rates UPC with a GF Score™ of 64/100 and a GF Value™ of $5.17 (Modestly Undervalued). The stock has 7 warning signs investors should review.

Universe Pharmaceuticals's Ending Cash Position for the quarter that ended in Sep. 2025 was $33.59 Mil.

Universe Pharmaceuticals's quarterly Ending Cash Position increased from Sep. 2024 ($29.50 Mil) to Mar. 2025 ($47.27 Mil) but then declined from Mar. 2025 ($47.27 Mil) to Sep. 2025 ($33.59 Mil).

Universe Pharmaceuticals's annual Ending Cash Position increased from Sep. 2023 ($5.29 Mil) to Sep. 2024 ($29.50 Mil) and increased from Sep. 2024 ($29.50 Mil) to Sep. 2025 ($33.59 Mil).

Universe Pharmaceuticals Ending Cash Position Related Terms

Universe Pharmaceuticals Ending Cash Position Historical Data

* Premium members only.

The historical data trend for Universe Pharmaceuticals's Ending Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Universe Pharmaceuticals Ending Cash Position Chart

Universe Pharmaceuticals Annual Data
Trend Sep18 Sep19 Sep20 Sep21 Sep22 Sep23 Sep24 Sep25
Ending Cash Position
Get a 7-Day Free Trial 8.08 5.71 5.29 29.50 33.59

Universe Pharmaceuticals Semi-Annual Data
Sep18 Mar19 Sep19 Mar20 Sep20 Mar21 Sep21 Mar22 Sep22 Mar23 Sep23 Mar24 Sep24 Mar25 Sep25
Ending Cash Position Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 5.29 8.86 29.50 47.27 33.59
UPC
64GF Score
Universe Pharmaceuticals Inc UPC
Ending Cash Position is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Universe Pharmaceuticals Ending Cash Position Calculation

Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. It is equal to the Beginning Cash Position plus the Net Change in Cash.

Universe Pharmaceuticals's Ending Cash Position for the fiscal year that ended in Sep. 2025 is calculated as

Ending Cash Position= Beginning Cash Position+Net Change in Cash
=29.498+4.094
=33.59

Universe Pharmaceuticals's Ending Cash Position for the quarter that ended in Sep. 2025 is calculated as

Ending Cash Position=Beginning Cash Position+Net Change in Cash
=47.273+-13.681
=33.59

Frequently Asked Questions Learn more about Ending Cash Position →
What does a Ending Cash Position of $33.59 Mil mean?
Universe Pharmaceuticals (UPC) has a Ending Cash Position of $33.59 Mil as of Sep. 2025. Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. View historical data on Universe Pharmaceuticals and its competitors.
Is Universe Pharmaceuticals' Ending Cash Position too high?
Universe Pharmaceuticals' current Ending Cash Position is $33.59 Mil. Overall, Universe Pharmaceuticals has a GF Score™ of 64/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Universe Pharmaceuticals' Ending Cash Position compare to CPMD and SHPH?
Universe Pharmaceuticals' Ending Cash Position of $33.59 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Ending Cash Position for a Drug Manufacturers company?
A good Ending Cash Position depends on the Drug Manufacturers industry context. However, Ending Cash Position should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Ending Cash Position mean?
A high Ending Cash Position can signal that a stock is expensive relative to its fundamentals. Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. View historical data on Universe Pharmaceuticals and its competitors. Universe Pharmaceuticals's current Ending Cash Position is $33.59 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Universe Pharmaceuticals stock overvalued right now?
Based on GuruFocus' analysis, Universe Pharmaceuticals (UPC) is currently considered Modestly Undervalued. The stock's GF Value™ is $5.17, compared to a current price of $4.45 — trading 13.9% below its estimated fair value. The current Ending Cash Position is $33.59 Mil. Universe Pharmaceuticals' overall GF Score™ is 64/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Ending Cash Position calculated?
Ending Cash Position is calculated from a company's financial statements. For Universe Pharmaceuticals (UPC), the current Ending Cash Position is $33.59 Mil as of Sep. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Universe Pharmaceuticals (UPC) Overvalued in 2026?

Based on GuruFocus' analysis, Universe Pharmaceuticals stock appears to be undervalued. The current stock price of $4.45 is trading 13.9% below its estimated GF Value™ of $5.17. GuruFocus considers Universe Pharmaceuticals to be Modestly Undervalued.

Key valuation signals for UPC:

  • Ending Cash Position: $33.59 Mil
  • GF Value™: $5.17 vs. price of $4.45 (13.9% below fair value)
  • GF Score™: 64/100 with 7 warning signs

No single metric tells the full story. See the UPC stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Universe Pharmaceuticals Business Description

Address 265 Jingjiu Avenue, Jinggangshan Economic & Technological Development Zone, Jiangxi, Ji’an, CHN, 343100
Universe Pharmaceuticals Inc is a pharmaceutical company specializing in the manufacturing, marketing, sales and distribution of traditional Chinese medicine derivatives products targeting the elderly with the goal of addressing their physical conditions in the ageing process and promoting their general well-being. The company also sells biomedical drugs, medical instruments, Traditional Chinese Medicine Pieces, and dietary supplements manufactured by third-party pharmaceutical companies. Its products are under two categories namely treatment and relief for common chronic health conditions in the elderly designed to achieve physical wellness and longevity (Chronic Condition Treatments), and cold and flu medications.
64GF Score

Get the complete analysis for UPC

Ending Cash Position is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$4.45
Price
$5.17
GF Value